Remedium Capital Partners, LLC
Top Portfolio Positions
5 positions ·
$274,513,954 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
1,565,661 | $76,795,672 | 27.98% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
1,456,231 | $73,452,291 | 26.76% | |
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
2,045,473 | $52,977,750 | 19.30% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
583,591 | $49,120,854 | 17.89% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
1,577,750 | $22,167,387 | 8.08% |
Portfolio Trend
2 quarters · across all stocks
Holdings in APGE
Shares Held
Position Value (USD)
2 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $49,120,854 | 583,591 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $44,049,448 | 583,591 | Shares | Sole | 2026-02-12 | |
| No 13F history on record for this holder in this stock. | ||||||